|
Volumn 13, Issue 3, 2003, Pages 437-442
|
Discovery of orally bioavailable NK1 receptor antagonists
a a a a b b a a a a a a a a b a
a
UCB PHARMA
(Belgium)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE;
3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE;
3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE;
3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE;
APREPITANT;
CALCIUM CHANNEL L TYPE;
PIPERAZINE DERIVATIVE;
ARTICLE;
BINDING AFFINITY;
DRUG BIOAVAILABILITY;
DRUG SCREENING;
MOLECULAR INTERACTION;
ACYLATION;
ALKYLATION;
ANIMALS;
BIOLOGICAL AVAILABILITY;
CARBOXYLIC ACIDS;
CHEMISTRY, PHYSICAL;
CHO CELLS;
CRICETINAE;
CRYSTALLOGRAPHY, X-RAY;
GUINEA PIGS;
HUMANS;
INDICATORS AND REAGENTS;
MODELS, MOLECULAR;
MOLECULAR CONFORMATION;
NITROGEN;
PIPERAZINES;
PULMONARY EDEMA;
RECEPTORS, NEUROKININ-1;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0037331022
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(02)00956-3 Document Type: Article |
Times cited : (6)
|
References (12)
|